Literature DB >> 24975428

Predicting pneumococcal community-acquired pneumonia in the emergency department: evaluation of clinical parameters.

S M Huijts1, W G Boersma, D E Grobbee, W C Gruber, K U Jansen, J A J W Kluytmans, B A F Kuipers, F Palmen, M W Pride, C Webber, M J M Bonten.   

Abstract

The aim of this study was to quantify the value of clinical predictors available in the emergency department (ED) in predicting Streptococcus pneumoniae as the cause of community-acquired pneumonia (CAP). A prospective, observational, cohort study of patients with CAP presenting in the ED was performed. Pneumococcal aetiology of CAP was based on either bacteraemia, or S. pneumoniae being cultured from sputum, or urinary immunochromatographic assay positivity, or positivity of a novel serotype-specific urinary antigen detection test. Multivariate logistic regression was used to identify independent predictors and various cut-off values of probability scores were used to evaluate the usefulness of the model. Three hundred and twenty-eight (31.0%) of 1057 patients with CAP had pneumococcal CAP. Nine independent predictors for pneumococcal pneumonia were identified, but the clinical utility of this prediction model was disappointing, because of low positive predictive values or a small yield. Clinical criteria have insufficient diagnostic capacity to predict pneumococcal CAP. Rapid antigen detection tests are needed to diagnose S. pneumoniae at the time of hospital admission.
© 2014 The Authors Clinical Microbiology and Infection © 2014 European Society of Clinical Microbiology and Infectious Diseases.

Entities:  

Keywords:  Community-acquired pneumonia; Streptococcus pneumoniae; diagnosis; prediction rule; urinary antigen test

Mesh:

Year:  2014        PMID: 24975428     DOI: 10.1111/1469-0691.12740

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  5 in total

1.  Comparative evaluation of the novel IMMUNOCATCHTM Streptococcus pneumoniae (EIKEN CHEMICAL CO., LTD) test with the Uni-GoldTM Streptococcus pneumoniae assay and the BinaxNOW® Streptococcus pneumoniae antigen card for the detection of pneumococcal capsular antigen in urine samples.

Authors:  F Congestrì; M Morotti; R Vicari; M F Pedna; M Sparacino; A Torri; S Bertini; M Fantini; V Sambri
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-12-19       Impact factor: 3.267

Review 2.  Impact of pneumococcal conjugate vaccines on hospitalizations for pneumonia in the United States.

Authors:  Andrew D Wiese; Marie R Griffin; Carlos G Grijalva
Journal:  Expert Rev Vaccines       Date:  2019-03-20       Impact factor: 5.217

3.  Pneumococcal and Legionella Urinary Antigen Tests in Community-acquired Pneumonia: Prospective Evaluation of Indications for Testing.

Authors:  Shawna Bellew; Carlos G Grijalva; Derek J Williams; Evan J Anderson; Richard G Wunderink; Yuwei Zhu; Grant W Waterer; Anna M Bramley; Seema Jain; Kathryn M Edwards; Wesley H Self
Journal:  Clin Infect Dis       Date:  2019-05-30       Impact factor: 9.079

4.  Atypical aetiology in patients hospitalised with community-acquired pneumonia is associated with age, gender and season; a data-analysis on four Dutch cohorts.

Authors:  Vivian M Raeven; Simone M C Spoorenberg; Wim G Boersma; Ewoudt M W van de Garde; Suzanne C Cannegieter; G P Paul Voorn; Willem Jan W Bos; Jim E van Steenbergen
Journal:  BMC Infect Dis       Date:  2016-06-17       Impact factor: 3.090

Review 5.  Evolving Understanding of the Causes of Pneumonia in Adults, With Special Attention to the Role of Pneumococcus.

Authors:  Daniel M Musher; Michael S Abers; John G Bartlett
Journal:  Clin Infect Dis       Date:  2017-10-30       Impact factor: 9.079

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.